Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 1472-1477, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Jong, J. G.
Right arrow Articles by Poorthuis, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Jong, J. G.
Right arrow Articles by Poorthuis, B. J.

Clinical Chemistry, Vol 35, 1472-1477, Copyright © 1989 by American Association for Clinical Chemistry

Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses

JG de Jong, RA Wevers, C Laarakkers and BJ Poorthuis
University Hospital Nijmegan, Institute Neurology, The Netherlands.

Glycosaminoglycans (GAGs) are measured in urine to screen for mucopolysaccharidoses. Other assay procedures are only qualitative (spot tests), can give false-negative results (spot tests, turbidity tests), or are relatively laborious (uronic acid-carbazole test). The present spectrophotometric procedure, based on the color reaction with dimethylmethylene blue (DMB), can be performed directly on untimed urine samples without prior precipitation. Reference values were age dependent. We tested urines of 27 patients with various mucopolysaccharidoses and compared results by three other procedures (cetylpyridinium chloride turbidity tests at pH 4.8 and at pH 7.0, and the uronic acid-carbazole test). In the DMB assay, GAGs were increased in 26 of the 27 patients. The exception was a Morquio A patient, whose activity of the defective enzyme was higher than in classical Morquio patients. Uronic acid, measured in precipitated GAG by the carbazole test, was increased in 23 of the 25 patients so tested. In the turbidity test at pH 7.0, values were increased in 24 of the 27 patients. In contrast, with the citrate-buffered (pH 4.8) turbidity measurement, GAG content was increased in only 19 of the 27 patients. This rapid and easy DMB method is a reliable screening procedure for mucopolysaccharidoses and compares well with procedures used hitherto.


The following articles in journals at HighWire Press have cited this article:


Home page
 PediatricsHome page
A. Meyer, K. Kossow, A. Gal, C. Muhlhausen, K. Ullrich, T. Braulke, and N. Muschol
Scoring Evaluation of the Natural Course of Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
Pediatrics, November 1, 2007; 120(5): e1255 - e1261.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Jiao, P. C. Billings, M. P. O'Connell, F. S. Kaplan, E. M. Shore, and D. L. Glaser
Heparan Sulfate Proteoglycans (HSPGs) Modulate BMP2 Osteogenic Bioactivity in C2C12 Cells
J. Biol. Chem., January 12, 2007; 282(2): 1080 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Cardone, V. A. Polito, S. Pepe, L. Mann, A. D'Azzo, A. Auricchio, A. Ballabio, and M. P. Cosma
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
Hum. Mol. Genet., April 1, 2006; 15(7): 1225 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
A. Nalini and R. Christopher
Cerebral Glycolipidoses: Clinical Characteristics of 41 Pediatric Patients
J Child Neurol, June 1, 2004; 19(6): 447 - 452.
[Abstract] [PDF]

Home page
 J. Med. Genet.Home page
C E Beesley, D Burke, M Jackson, A Vellodi, B G Winchester, and E P Young
Sanfilippo syndrome type D: identification of the first mutation in the N-acetylglucosamine-6-sulphatase gene
J. Med. Genet., March 1, 2003; 40(3): 192 - 194.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M.-J. J. Pouwels, P. N. Span, C. J. Tack, A. J. Olthaar, C. G. J. Sweep, B. G. van Engelen, J. G. de Jong, J. A. Lutterman, and A. R. Hermus
Muscle Uridine Diphosphate-Hexosamines Do Not Decrease Despite Correction of Hyperglycemia-Induced Insulin Resistance in Type 2 Diabetes
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5179 - 5184.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. Yavuz, A. Toprak, Y. Budak, H. O. Ersoz, O. Deyneli, H. Tezcan, and S. Akalin
Urinary Glycosaminoglycan Excretion in Newly Diagnosed Essential Hypertensive Patients
Clin. Chem., February 1, 2000; 46(2): 299 - 301.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
T. Akçay, D. Konukoglu, and Y. Dínçer
Urinary glycosaminoglycan excretion in urolithiasis
Arch. Dis. Child., March 1, 1999; 80(3): 271 - 272.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
F Breier, S Fang-Kircher, K Wolff, and W Jurecka
Juvenile hyaline fibromatosis: impaired collagen metabolism in human skin fibroblasts
Arch. Dis. Child., November 1, 1997; 77(5): 436 - 440.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.